Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis

Surgical Infections

Volumn 10, Issue 5, 2009, Pages 407-417

  Emami, Claudia N ^a   Petrosyan, Mikael ^a   Giuliani, Stefano ^a   Williams, Monica ^a   Hunter, Catherine ^a   Prasadarao, Nemani V ^b   Ford, Henri R ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; GAMMA INTERFERON; GENTAMICIN; IMMUNOGLOBULIN A; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; NITRIC OXIDE; PROBIOTIC AGENT; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ARTIFICIAL MILK; BACTERIAL COLONIZATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; ENTERIC FEEDING; ENTEROBACTER SAKAZAKII; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; INFLAMMATION; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; MUCOSAL IMMUNITY; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTESTINAL MUCOSA;

EID: 72449122344     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2009.054     Document Type: Review

References (121)

1. Weidmeier SE, Henry V, Baer VL, et al. Center differences in NEC within one health-care system may depend on feeding protocol. Amer J Perinat 2008;25:5-11.
2. Peter C, Feuerhahn B, Bohnhorst M, et al. Necrotising enterocolitis: Is there a relationship to specific pathogens. J Pediatr Surg 1999;158:67-70.
3. www.cdc.gov=datastatistics=2007=births.
4. Boccia D, Stofli I, Lana S, Moro ML. Nosocomial necrotizing enterocolitis outbreaks: Epidemiology and control measures. Eur J Pediatr 2001;160:385-391.
5. Blakely ML, Lally KP, McDonald S, et al. Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: A prospective cohort study by the NICHD Neonatal Research Network. Ann Surg 2005;241:984-994.
6. Ford HR. Mechanism of nitric oxide-mediated intestinal barrier failure: Insight into the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 2006;41:294-299.
7. Grishin A, Ford H, Wang J, et al. Attenuation of apoptosis in enterocytes by blockaDe of potassium channels. Am J Physiol Gastrointest Liver Physiol 2005;289:G815-G821.
8. Grishin A, Wang J, Hackam D, et al. p38 MAP kinase mediates endotoxin-induced expression of cyclooxygenase- 2 in enterocytes. Surgery 2004;136:329-335.
9. Grishin AV, Wang J, Potoka DA, et al. LipopolysacchariDe induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J Immunol 2006;176: 580-588.
10. Hackam DJ, Upperman JS, Grishin A, et al. Disordered enterocyte signaling and intestinal barrier dysfunction in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 2005;14:49-57.
11. Kelly N, Friend K, Boyle P, et al. The role of the glutathione antioxidant system in gut barrier failure in a rodent model of experimental necrotizing enterocolitis. Surgery 2004;136: 557-566.
12. Nadler EP, Boyle P, Murdock AD, et al. Newborn endothelin receptor type B mutant (piebald) mice have a higher resting anal sphincter pressure than newborn C57BL=6 mice. Contemp Top Lab Anim Sci 2003;42:36-38.
13. Neal MD, Leaphart C, Levy R, et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 2006;176:3070-3079.
14. Podd BS, Aberg C, Christopher TL, et al. Late postnatal expansion of self-reactive CD8alphaalpha+ intestinal intraepithelial lymphocytes in mice. Autoimmunity 2004;37: 537-547.
15. Podd BS, Thoits J, Whitley N, et al. T cells in cryptopatch aggregates share TCR gamma variable region junctional sequences with gamma delta T cells in the small intestinal epithelium of mice. J Immunol 2006;176:6532-6542.
16. Potoka DA, Nadler EP, Upperman JS, et al. Role of nitric oxiDe and peroxynitrite in gut barrier failure. World J Surg 2002;26:806-811.
17. Potoka DA, Upperman JS, Nadler EP, et al. NF-kappaB inhibition enhances peroxynitrite-induced enterocyte apoptosis. J Surg Res 2002;106:7-14.
18. Sala FG, Curtis JL, Veltmaat JM, et al. Fibroblast growth factor 10 is required for survival and proliferation but not differentiation of intestinal epithelial progenitor cells during murine colon development. Dev Biol 2006;299:373-385.
19. Stanford A, Upperman JS, Boyle P, et al. Long-term followup of patients with necrotizing enterocolitis. J Pediatr Surg 2002;37:1048-1050.
20. Horbar JD, Onstad L, Wright E. Predicting mortality risk for infants weighing 501 to 1500 grams at birth: A National Institutes of Health Neonatal Research Network report. Crit Care Med 1993;21:12-18
21. Potoka DA, Upperman JS, Zhang XR, et al. Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro. Am J Physiol Gastrointest Liver Physiol 2003;285:G861-G869.
22. Upperman JS. Glutathione (GSH) levels in necrotizing enterocolitis (NEC). J Pediatr Surg 2005;40:1813.
23. Corfield AP, Myerscough NY, Longman R, et al. Mucin and mucosal protection in the gastrointestinal tract: New prospect for mucins in the pathology of gastrointestinal disease. Gut 2000;47:589-594.
24. Muller CA,Autenrieth IB, PeschelA. Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci 2005;62:1297-1307.
25. Fagarason S, Tasuku H. Intestinal IgA synthesis: Regulation of front-line body defenses. Nat Rev 2003;3:63-72.
26. Artis D. Epithelial cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008;8:411-420.
27. Otte JM, Kiehne K, Herzig KH. Antimicrobial peptides in innate immunity of the human intestine. J Gastroenterol 2003;38:717-726.
28. Bevins CH. Events at the host-microbial interface of the gastrointestinal tract V. Paneth cell alpha-defensins in intestinal host defense. Am J Physiol Gastroenterol Liver Physiol 2005;289:G173-G176.
29. Neu J, Chen M, Beierle E. Intestinal innate immunity: How does it relate to the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg 2005;14:137-144.
30. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006;86:245-278.
31. Strous GJ, Dekker J. Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 1992;27:57-92.
32. Einerhand AW, Renes IB, Makkink MK, et al. Role of mucins in inflammatory bowel disease: Important lessons from experimental models. Eur J Gastroenterol Hepatol 2002;14:757-765.
33. Allen A, Bell A, Mantle M, Pearson JP. The structure and physiology of gastrointestinal mucus. Adv Exp Med Biol 1982;144:115-133.
34. Montagne L, Piel C, Lalles JP. Effect of diet on mucin kinetics and composition: Nutrition and health implications. Nutr Rev 2004;62:105-114.
35. Rhodes JM. Colonic mucus and mucosal glycoproteins: The key to colitis and cancer? Gut 1989;30:1660-1666.
36. Uhlig HH, Powrie F. The role of mucosal T lymphocytes in regulating intestinal inflammation. Springer Semin Immunopathol 2005;27:167-180.
37. Chen Y, Chou K, Fuchs E, et al. Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA 2002;99:14338-14343.
38. Mackie R, Sghir A, Gaskins R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999;69:1035S-1045S.
39. Hoffmann JC, Peters K, Henschke S, et al. Role of T lymphocytes in rat 2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis: Increased mortality after gammadelta T cell depletion and no effect of alphabeta T cell depletion. Gut 2001;48:489-495.
40. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-1118.
41. Hooper LV. Bacterial contributions to mammalian gut development. Trends Microbiol 2004;12:129-134.
42. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69:1052S-1057S.
43. Bernt MF, Brassart D, Neeser JR, et al. Lactobacillus acidophilus LA 1 binds to culture of human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994;35:483-489.
44. Turner JR. Molecular basis of epithelial barrier regulation: From basic mechanisms to clinical application. Am J Pathol 2006;169:1901-1909.
45. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions IV. Regulation of tight junctions by extracellular stimuli: Nutrients, cytokines and immune cells. Am J Physiol Gastroenterol Liver Physiol 2000;279:G851-G857.
46. Yu QH, Yang Q. Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier. Cell Biol Int 2009;33:78-82.
47. Kamm KE, Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 2001;276:4527-4530.
48. Guo Y, Ramachandran C, Satpathy M, Srinivas SP. Histamine-induced myosin light chain phosphorylation breaks down the barrier integrity of cultured corneal epithelial cells. Pharm Res 2007;24:1824-1833.
49. Cetin S, Leaphart C, Li J, et al. Nitric oxiDe inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2 dependent manner. Am J Physiol Gastrointest Liver Physiol 2007;292:G1347-G1358.
50. Boivin MA, Ye D, Kennedy JC, et al. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2007;292: G590-G598.
51. Clayburgh DR, Rosen S, Witkowski ED, et al. A differentiation-dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability. J Biol Chem 2004;279:55506-55513.
52. Han X, Fink MP, DeluDe RL. Proinflammatory cytokines cause NO*-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 2003;19:229-237.
53. Nusrat A, Von Eichel-Streiber C, Turner JR, et al. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun 2001;69:1329-1336.
54. Simonovic I, Rosenberg J, Koutsouris A, Hecht G. Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol 2000;2:305-315.
55. Forcielli M, Walker A. The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr 2005;93:S41-S48.
56. Holman RC, Stoll BJ, Clarke MJ, et al. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health 1997;87:2026-2031.
57. Martin JA, Hamilton BE, Sutton PD, et al. Births: Final data for 2004. Natl Vital Stat Rep 2006;55:1-101.
58. Lin P, Nasr T, Stoll JB. Necrotizing enterocolitis: Recent scientific advances in pathophysiology and prevention. Semin Perinatol 2008;37:70-82.
59. Horbar JD, Badger GI, Carpenter GH, et al. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002;110:143-151.
60. Sankaran K, Puckett B, Lee DS, et al. Variations in incidence of necrotizing enterocolitis in Canadian neonatal intensive care units. J Pediatr Gastroenterol Nutr 2004;39:366-372.
61. Sase M, Miwa I, Sumie M, et al. Ontogeny of gastric emptying patterns in human fetus. Am J Matern Fetal Med 2005;17:213-217. (Pubitemid 40992341)
62. Sanderson IR. The physiochemical environment of the neonatal intestine. Am J Clin Nutr 1999;69:1028S-1034S.
63. Berseth CL, McCoy HH. Birth asphyxia alters neonatal intestine motility in term neonates. Pediatrics 1992;90:669-673.
64. Goldman AS, Ogra PL. Anti-infectious and infectious agents in human milk. In: Mestecky J, Lamm M, Strober W, et al., eds. Mucosal Immunology (Vol. 1). San Diego CA: Academic Press, 1999:72-85.
65. Ozturk H, Dokucu AI, Ogun C, et al. Protective effects of recombinant human interleukin-10 on intestines of hypoxia induced necrotizing enterocolitis in immature rats. J Pediatr Surg 2002;37:1330-1333.
66. Fituch CC, Palkowetz KH, Goldman AS, et al. Concentration of IL-10 in preterm human milk and in milk from mothers of infants with necrotizing enterocolitis. Acta Paediatr 2004;93:1496-1500.
67. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002;68: 219-226.
68. Chan KL, Saing H, Yung RW, et al. A study of pre-antibiotic bacteriology in 125 patients with necrotizing enterocolitis. Acta Paediatr Suppl 1994;396:45-48.
69. McGuire W, Anthonyn MY. Donor milk versus formula for preventing necrotizing enterocolitis in preterm infants: Systemic review. Arch Dis Child Fetal Neonatal Ed 2003; 88:F11-F14.
70. Henderson G, Craig S, Brockehurst P, et al. Enteral feeding regimens and necrotizing enterocolitis in preterm infants: A multicenter case control study. Arch Dis Child Fetal Neonatal Ed 2009;94:F120-F123.
71. Meinzen-Derr J, Poindexter B, Wrage L, et al. Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol 2009;29:57-62.
72. Udall JN, Pang K, Fritz L. Development of gastrointestinal mucosal barrier: I. effect of age on intestinal permeability to macromolecules. Ped Res. 1981;15:241-244.
73. Gordon JI, Hermiston ML. Differentiation and self-renewal in the mouse gastrointestinal epithelium. Curr Opin Cell Biol 1994;6:795-803.
74. Herbst JJ, Sunshine P. Postnatal development of the small intestine of the rat. Pediatr Res 1969;3:27-33.
75. Bandeira A, Itohara S, Bonneville M, et al. Extrathymic origin of intestinal intraepithelial lymphocytes bearing Tcell antigen receptor gamma delta. Proc Natl Acad Sci USA 1991;88:43-47.
76. Colgan SP, Resnick MB, Parkos CA, et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 1994;153:2122-2129.
77. Penttila IA, van Spriel AB, Zhang MF, et al. Transforming growth factor-beta levels in maternal milk and expression in postnatal rat duodenum and ileum. Pediatr Res 1998; 44:524-531.
78. Lyscom N, Brueton MJ. The impact of post-weaning protein malnutrition on intraepithelial and Peyer's patch lymphocyte sub-types in rat small bowel. Immunology 1983;50:511-514.
79. Leaphart CL, Qureshi F, Cetin S, et al. Interferon-gamma inhibits intestinal restitution by preventing gap junction communication between enterocytes. Gastroenterology 2007;132:2395-2411.
80. Nadler EP, Dickinson E, Kinsely A, et al. Expression of inducible nitric oxiDe synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 2000;92:71-77.
81. Hsueh W, Caplan M, Qu X, et al. Neonatal necrotising enterocolitis: Clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2002;6:6-23.
82. Chan KL, Ho JC, Chan KW, et al. A study of gut immunity to enteral endotoxin in rats of different ages: A possible cause of necrotizing enterocolitis. J Pediatr Surg 2002;37: 1435-1440.
83. Chan KL, Hui WC, Chan KW, et al. Revisiting ischemia and reperfusion injury as possible cause of necrotizing enterocolitis: Role of nitric oxiDe and super oxiDe dismutase. J Pediatr Surg 2002;37:828-834.
84. Chokshi N, Guner Y, Hunter CJ, et al. The role of nitric oxiDe in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin Perinatol 2008;32:92-99.
85. Potoka DA, Upperman JS, Nadler EP, et al. NF-kappaB inhibition enhances peroxynitrite-induced enterocyte apoptosis. J Surg Res 2002;106:7-14.
86. Ford H, Watkins S, Reblock K, et al. The role of inflammatory cytokines and nitric oxiDe in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997;32:275-282.
87. Hacham D, Upperman JS, Grishin A. Disordered enterocyte signaling and intestinal barrier dysfunction in the pathogenesis of necrotizing enterocolitis. Pediatr Crit Care Med 2005;6:S108-S111.
88. Potoka DA, Nadler EP, Upperman JS, Ford HR. Role of nitric oxiDe and peroxynitrite in gut barrier failure. World J Surg 2002;26:806-811.
89. Ford H, Reblock K, Teramana C, et al. The role of nitric oxiDe in the pathogenesis of necrotizing enterocolitis. Surg Forum 1995;46:642-644.
90. Fast C, Rosegger H. Necrotizing enterocolitis prophylaxis: Oral antibiotics and lyophilized enterobacteria vs oral immunoglobulins [see comments]. Acta Paediatr Suppl 1994; 396:86-90.
91. Peter CS, Feuerhahn M, Bohnhorst B, et al. Necrotising enterocolitis: Is there a relationship to specific pathogens? Eur J Pediatr 1999;158:67-70.
92. Chan KL, Saing H, Yung RW, et al. A study of pre-antibiotic bacteriology in 125 patients with necrotizing enterocolitis. Acta Paediatr Suppl 1994;396:45-48.
93. Martin CR, Walker WA. Probiotics: Role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 2008;32:127-137.
94. Hunter CJ, Upperman JS, Ford HR, Camerini V. Understanding the susceptibility of premature infant to necrotizing enterocolitis (NEC). Pediatr Res 2008;63:117-123.
95. Medzhitov R, Preston P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
96. Poltorak A, Smirnova M, Liu C, et al. Defective LPS signaling in C3H=HeJ and C57BL=10Sc CR mice: Mutations in the TLR4 genes. Science 1998;282:2085-2088.
97. Leaphart CT, Cavallo J, Gribar SC, et al. A critical role for TLR 4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 2007; 179:4808-4820.
98. Caplan MS, Miller R, Kaup S, et al. Bifidobacterium supplementation reduces the incidence of encrotising enterocolitis in neonatal rat model. Gastroenterology 1999;117:577-583.
99. Jilling T, Simon D, Lu J, et al. The role of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 2006;177:3273-3282.
100. Farmer JJ, Ashbury F, Hickman DJ, et al. Enterobacter sakazakii: A new species of Enterobacteriaceae isolated from clinical material. Int J Syst Bacteriol 1980;30:568-584.
101. Hunter CJ, Petrosyan M, Ford HR, Prasadarao NV. Enterobacter sakazakii: An emerging pathogen in infants and neonates. Surg Infect 2008;9:533-539.
102. Muytjens HL, Zanen HC, Sonderkamp HJ, et al. Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol 1983;18:115-120.
103. van Acker J, De Smet F, Muyldermans G, et al. Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol 2001;39: 293-297.
104. Simmons BP, Gelfand MH, Metts L, et al. Enterobacter sakazakii infections in neonates associated with intrinsic contamination of powdered infant formula. Control Hosp Epidemiol 1989;10:389-401.
105. Hunter CJ, Singamsetty VK, Chokshi NK, et al. Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis. J Infect Dis 2008;198:586-593.
106. Selvaraj SK, Prasadarao NV. E. coli K1 inhibits pro inflammatory cytokine induction in monocytes by preventing NF-kB activation. J Leukoc Biol 2005;78:544-554.
107. AO=WHO. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO=WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. www.who.int=entity= foodsafety=fs-managementlen=probiotic-guidelines.pdf.
108. Cabana MD, Shane AL, Cao C, et al. Probiotics in primary care pediatrics. Clin Pediatr (Phila) 2006;45:405-410.
109. Saavedra JM. Clinical applications of probiotic agents. Am J Clin Nutr 2001;73:11475-11515.
110. Manzoni P. Use of lactobacillus casei subspecies rhamnosus gg and gastrointestinal colonization by candida species in preterm neonates. J Ped Gastroent Nutr 2006;43:550-557.
111. NASPGHAN Nutrition Report Committee: Michail S, Sylvester F, Fuchs G, Issenman R. Clinical efficacy of probiotics: review of the evidence with focus on children. J Ped Gastroent Nutr 2006;43:550-557.
112. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight infants. J Pediatr 2005;147:192-196.
113. Gewolb I, Schwalbe R, Taciak V, et al. Stool microflora in extremely low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1999;80:F167-F173.
114. Panders J, Thijis C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006;118:511-521.
115. Masco L, Ventura M, Zink R, et al. Polyphasic taxonomic analysis of B. animalis and B. lactis relatedness at the subspecies level. Int J Syst Evol Microbiol 2004;54:1137-1143.
116. Martin CR, Walker AW. Probiotics: Role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 2008;32:127-137.
117. Alfalah KM, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2008;(1):CD005496.
118. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999;3:197-202.
119. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduced the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4.
120. Bin-Nun A, Bromiker R, Wischanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-196.
121. Hunter CJ, Williams M, Petrosyan M, et al. Lactobacillus bulgaris prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxiDe both in-vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun 2009;77:1031-1043.